CEACAM5 and medullary thyroid gland carcinoma: Moreover, in MTC patients undergoing cytotoxic chemotherapy, an increase in serum CEA levels three months postoperatively serves as a reliable surrogate marker for predicting shorter progression-free survival (PFS) (100).